Phase II oncology trials: let's be positive
- PMID: 16115898
- DOI: 10.1158/1078-0432.CCR-05-1046
Phase II oncology trials: let's be positive
Comment on
-
Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval.Clin Cancer Res. 2005 Aug 15;11(16):5928-34. doi: 10.1158/1078-0432.CCR-05-0130. Clin Cancer Res. 2005. PMID: 16115935 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
